AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders
Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these...
Gespeichert in:
| Veröffentlicht in: | Fortschritte der Neurologie, Psychiatrie Psychiatrie, 2004-12, Vol.72 (12), p.679 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 12 |
| container_start_page | 679 |
| container_title | Fortschritte der Neurologie, Psychiatrie |
| container_volume | 72 |
| creator | Thomasius, R Gouzoulis-Mayfrank, E Karus, C Wiedenmann, H Hermle, L Sack, P M Zeichner, D Küstner, U Schindler, A Krüger, A Uhlmann, S Petersen, K U Zapletalova, P Wartberg, L Schütz, C G Schulte-Markwort, M Obrocki, J Heinz, A Schmoldt, A |
| description | Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced. |
| doi_str_mv | 10.1055/s-2004-818531 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_15580533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15580533</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-2a4e2e44ff79a42ce2a40c544062289369ad387b3d4b7100068bef94a89002333</originalsourceid><addsrcrecordid>eNo1jztPwzAUhT2AaCmMrCg_AMP1K7HZqooCUhEDIMbqxr5pg_KSnQz991QqTOd8Z_ikw9iNgHsBxjwkLgE0t8IaJc7YHAoJXEvnZuwypR8AoZ0oLthMGGPBKDVnH8vvtzXfTXWgpu7oMfO9x2Phdxm2w55GbE9EPo2YDjzDLmR7bJrJ112_o45HanCkkIU69TFQTFfsvMIm0fVfLtjX-ulz9cI378-vq-WGD0K5kUvUJEnrqiocaunpOIA3WkMupXUqdxiULUoVdFkIAMhtSZXTaB2AVEot2O3JO0xlS2E7xLrFeNj-v1O_jP5N8g</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Thomasius, R ; Gouzoulis-Mayfrank, E ; Karus, C ; Wiedenmann, H ; Hermle, L ; Sack, P M ; Zeichner, D ; Küstner, U ; Schindler, A ; Krüger, A ; Uhlmann, S ; Petersen, K U ; Zapletalova, P ; Wartberg, L ; Schütz, C G ; Schulte-Markwort, M ; Obrocki, J ; Heinz, A ; Schmoldt, A</creator><creatorcontrib>Thomasius, R ; Gouzoulis-Mayfrank, E ; Karus, C ; Wiedenmann, H ; Hermle, L ; Sack, P M ; Zeichner, D ; Küstner, U ; Schindler, A ; Krüger, A ; Uhlmann, S ; Petersen, K U ; Zapletalova, P ; Wartberg, L ; Schütz, C G ; Schulte-Markwort, M ; Obrocki, J ; Heinz, A ; Schmoldt, A ; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft</creatorcontrib><description>Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.</description><identifier>ISSN: 0720-4299</identifier><identifier>DOI: 10.1055/s-2004-818531</identifier><identifier>PMID: 15580533</identifier><language>ger</language><publisher>Germany</publisher><subject>Adult ; Amphetamine-Related Disorders - therapy ; Cocaine-Related Disorders - therapy ; Comorbidity ; Evidence-Based Medicine ; Female ; Hallucinogens ; Humans ; N-Methyl-3,4-methylenedioxyamphetamine ; Pregnancy ; Substance-Related Disorders - physiopathology ; Substance-Related Disorders - therapy</subject><ispartof>Fortschritte der Neurologie, Psychiatrie, 2004-12, Vol.72 (12), p.679</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15580533$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomasius, R</creatorcontrib><creatorcontrib>Gouzoulis-Mayfrank, E</creatorcontrib><creatorcontrib>Karus, C</creatorcontrib><creatorcontrib>Wiedenmann, H</creatorcontrib><creatorcontrib>Hermle, L</creatorcontrib><creatorcontrib>Sack, P M</creatorcontrib><creatorcontrib>Zeichner, D</creatorcontrib><creatorcontrib>Küstner, U</creatorcontrib><creatorcontrib>Schindler, A</creatorcontrib><creatorcontrib>Krüger, A</creatorcontrib><creatorcontrib>Uhlmann, S</creatorcontrib><creatorcontrib>Petersen, K U</creatorcontrib><creatorcontrib>Zapletalova, P</creatorcontrib><creatorcontrib>Wartberg, L</creatorcontrib><creatorcontrib>Schütz, C G</creatorcontrib><creatorcontrib>Schulte-Markwort, M</creatorcontrib><creatorcontrib>Obrocki, J</creatorcontrib><creatorcontrib>Heinz, A</creatorcontrib><creatorcontrib>Schmoldt, A</creatorcontrib><creatorcontrib>Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft</creatorcontrib><title>AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders</title><title>Fortschritte der Neurologie, Psychiatrie</title><addtitle>Fortschr Neurol Psychiatr</addtitle><description>Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.</description><subject>Adult</subject><subject>Amphetamine-Related Disorders - therapy</subject><subject>Cocaine-Related Disorders - therapy</subject><subject>Comorbidity</subject><subject>Evidence-Based Medicine</subject><subject>Female</subject><subject>Hallucinogens</subject><subject>Humans</subject><subject>N-Methyl-3,4-methylenedioxyamphetamine</subject><subject>Pregnancy</subject><subject>Substance-Related Disorders - physiopathology</subject><subject>Substance-Related Disorders - therapy</subject><issn>0720-4299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jztPwzAUhT2AaCmMrCg_AMP1K7HZqooCUhEDIMbqxr5pg_KSnQz991QqTOd8Z_ikw9iNgHsBxjwkLgE0t8IaJc7YHAoJXEvnZuwypR8AoZ0oLthMGGPBKDVnH8vvtzXfTXWgpu7oMfO9x2Phdxm2w55GbE9EPo2YDjzDLmR7bJrJ112_o45HanCkkIU69TFQTFfsvMIm0fVfLtjX-ulz9cI378-vq-WGD0K5kUvUJEnrqiocaunpOIA3WkMupXUqdxiULUoVdFkIAMhtSZXTaB2AVEot2O3JO0xlS2E7xLrFeNj-v1O_jP5N8g</recordid><startdate>200412</startdate><enddate>200412</enddate><creator>Thomasius, R</creator><creator>Gouzoulis-Mayfrank, E</creator><creator>Karus, C</creator><creator>Wiedenmann, H</creator><creator>Hermle, L</creator><creator>Sack, P M</creator><creator>Zeichner, D</creator><creator>Küstner, U</creator><creator>Schindler, A</creator><creator>Krüger, A</creator><creator>Uhlmann, S</creator><creator>Petersen, K U</creator><creator>Zapletalova, P</creator><creator>Wartberg, L</creator><creator>Schütz, C G</creator><creator>Schulte-Markwort, M</creator><creator>Obrocki, J</creator><creator>Heinz, A</creator><creator>Schmoldt, A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200412</creationdate><title>AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders</title><author>Thomasius, R ; Gouzoulis-Mayfrank, E ; Karus, C ; Wiedenmann, H ; Hermle, L ; Sack, P M ; Zeichner, D ; Küstner, U ; Schindler, A ; Krüger, A ; Uhlmann, S ; Petersen, K U ; Zapletalova, P ; Wartberg, L ; Schütz, C G ; Schulte-Markwort, M ; Obrocki, J ; Heinz, A ; Schmoldt, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-2a4e2e44ff79a42ce2a40c544062289369ad387b3d4b7100068bef94a89002333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Amphetamine-Related Disorders - therapy</topic><topic>Cocaine-Related Disorders - therapy</topic><topic>Comorbidity</topic><topic>Evidence-Based Medicine</topic><topic>Female</topic><topic>Hallucinogens</topic><topic>Humans</topic><topic>N-Methyl-3,4-methylenedioxyamphetamine</topic><topic>Pregnancy</topic><topic>Substance-Related Disorders - physiopathology</topic><topic>Substance-Related Disorders - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomasius, R</creatorcontrib><creatorcontrib>Gouzoulis-Mayfrank, E</creatorcontrib><creatorcontrib>Karus, C</creatorcontrib><creatorcontrib>Wiedenmann, H</creatorcontrib><creatorcontrib>Hermle, L</creatorcontrib><creatorcontrib>Sack, P M</creatorcontrib><creatorcontrib>Zeichner, D</creatorcontrib><creatorcontrib>Küstner, U</creatorcontrib><creatorcontrib>Schindler, A</creatorcontrib><creatorcontrib>Krüger, A</creatorcontrib><creatorcontrib>Uhlmann, S</creatorcontrib><creatorcontrib>Petersen, K U</creatorcontrib><creatorcontrib>Zapletalova, P</creatorcontrib><creatorcontrib>Wartberg, L</creatorcontrib><creatorcontrib>Schütz, C G</creatorcontrib><creatorcontrib>Schulte-Markwort, M</creatorcontrib><creatorcontrib>Obrocki, J</creatorcontrib><creatorcontrib>Heinz, A</creatorcontrib><creatorcontrib>Schmoldt, A</creatorcontrib><creatorcontrib>Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Fortschritte der Neurologie, Psychiatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomasius, R</au><au>Gouzoulis-Mayfrank, E</au><au>Karus, C</au><au>Wiedenmann, H</au><au>Hermle, L</au><au>Sack, P M</au><au>Zeichner, D</au><au>Küstner, U</au><au>Schindler, A</au><au>Krüger, A</au><au>Uhlmann, S</au><au>Petersen, K U</au><au>Zapletalova, P</au><au>Wartberg, L</au><au>Schütz, C G</au><au>Schulte-Markwort, M</au><au>Obrocki, J</au><au>Heinz, A</au><au>Schmoldt, A</au><aucorp>Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders</atitle><jtitle>Fortschritte der Neurologie, Psychiatrie</jtitle><addtitle>Fortschr Neurol Psychiatr</addtitle><date>2004-12</date><risdate>2004</risdate><volume>72</volume><issue>12</issue><spage>679</spage><pages>679-</pages><issn>0720-4299</issn><abstract>Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.</abstract><cop>Germany</cop><pmid>15580533</pmid><doi>10.1055/s-2004-818531</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0720-4299 |
| ispartof | Fortschritte der Neurologie, Psychiatrie, 2004-12, Vol.72 (12), p.679 |
| issn | 0720-4299 |
| language | ger |
| recordid | cdi_pubmed_primary_15580533 |
| source | MEDLINE; Thieme Connect Journals |
| subjects | Adult Amphetamine-Related Disorders - therapy Cocaine-Related Disorders - therapy Comorbidity Evidence-Based Medicine Female Hallucinogens Humans N-Methyl-3,4-methylenedioxyamphetamine Pregnancy Substance-Related Disorders - physiopathology Substance-Related Disorders - therapy |
| title | AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A56%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AWMF-guideline:%20cocaine-,%20amphetamine-,%20ecstasy-%20and%20hallucinogen-related%20disorders&rft.jtitle=Fortschritte%20der%20Neurologie,%20Psychiatrie&rft.au=Thomasius,%20R&rft.aucorp=Arbeitsgemeinschaft%20der%20Wissenschaftlichen%20Medizinischen%20Fachgesellschaft&rft.date=2004-12&rft.volume=72&rft.issue=12&rft.spage=679&rft.pages=679-&rft.issn=0720-4299&rft_id=info:doi/10.1055/s-2004-818531&rft_dat=%3Cpubmed%3E15580533%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15580533&rfr_iscdi=true |